Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Motor Activity 2Breast Neoplasms 2Weight Loss 1Uterine Cervical Dysplasia 1Polycystic Ovary Syndrome 1Papillomavirus Infections 1Obesity 1Insulin Resistance 1Infertility, Female 1Infections 1Cognitive Dysfunction 1

Interventions

Exercise 6Transcranial Direct Current Stimulation 4Walking 3Memantine 3Tablets 2Standard of Care 2Methods 2Donepezil 2Cognitive Behavioral Therapy 2mazdutide 1lithium sulfate 1lime 1fasudil 1enzalutamide 1blueberry extract 1beta Carotene 1acetaminophen, aspirin, caffeine drug combination 1XENP 1595 1Vitamin E 1Vitamin D 1Ultraviolet Therapy 1Transcranial Magnetic Stimulation 1Time 1Therapeutics 1Tai Ji 1Sugars 1Sodium Chloride 1Sirolimus 1Silymarin 1Riluzole 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Cognitive Dysfunction × lime × Clear all
NCT06727773 2026-05-06

Memantine and Exercise to Improve Cognitive Function and Modulate Biological Pathways of Cognitive Decline During Chemotherapy in Breast Cancer

UNC Lineberger Comprehensive Cancer Center

Phase 2 Recruiting
90 enrolled
Breast

Breast Neoplasms, Motor Activity, Cognitive Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon âš¡